A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Herantis Pharma Certified Adviser change

Herantis Pharma Certified Adviser change Herantis Pharma Plc Company release 1 July 2015 at 10:00 am The shares of Herantis…

Read More

Herantis Pharma granted almost 3 million Euro government loan for Parkinson study

Herantis Pharma granted almost 3 million Euro government loan for Parkinson study Herantis Pharma Plc Company release 30 June 2015…

Read More

Scientific publication suggests Herantis' CDNF improves long-term memory in mouse model of Alzheimers

Scientific publication suggests Herantis' CDNF improves long-term memory in mouse model of Alzheimers Herantis Pharma Plc. Company release 3 June…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.